Terns Pharmaceuticals (TERN) Return on Equity (2020 - 2025)
Terns Pharmaceuticals filings provide 6 years of Return on Equity readings, the most recent being 0.0% for Q4 2025.
- Quarterly Return on Equity changed 0.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
- Return on Equity hit 0.0% in Q4 2025 for Terns Pharmaceuticals, down from 0.0% in the prior quarter.
- Across five years, Return on Equity topped out at 0.0% in Q4 2024 and bottomed at 0.01% in Q1 2021.
- Average Return on Equity over 5 years is 0.0%, with a median of 0.0% recorded in 2021.
- The largest annual shift saw Return on Equity changed 0bps in 2021 before it increased 1bps in 2022.
- Terns Pharmaceuticals' Return on Equity stood at 0.0% in 2021, then plummeted by -12862bps to 0.0% in 2022, then crashed by -34bps to 0.0% in 2023, then surged by 100bps to 0.0% in 2024, then tumbled by -33705bps to 0.0% in 2025.
- Per Business Quant, the three most recent readings for TERN's Return on Equity are 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).